Welcome to our dedicated page for Milestone Scient news (Ticker: MLSS), a resource for investors and traders seeking the latest updates and insights on Milestone Scient stock.
Milestone Scientific Inc. (MLSS) is described in its public disclosures as a technology-focused medical research and development company that patents, designs and develops computerized injection technologies and instruments for medical, dental and cosmetic applications. The company’s news flow centers on its computerized drug delivery instruments, which are designed to provide painless and precise injections using its DPS Dynamic Pressure Sensing Technology® platform.
News updates commonly cover developments in Milestone Scientific’s dental segment, including expansion of direct sales programs in North America, new international registrations for the STA® Single Tooth Anesthesia System, and initiatives such as The Wand® Ambassador Program. That program uses experienced dental professionals to share real-world clinical insights and workflow considerations to support broader adoption of The Wand STA System.
In the medical segment, news items highlight the CompuFlo® technology and the CompuFlo Epidural System, including growing utilization of CompuFlo disposables, interest from hospitals and international distributors, and progress on reimbursement strategies. Milestone Scientific reports milestones such as Medicare Part B payment-rate assignments under CPT® code 0777T in several jurisdictions and early activity from commercial insurers, which it views as important for adoption in interventional pain management and spine intervention markets.
Other recurring themes in Milestone Scientific’s news include quarterly financial results, cost-management and operational transformation efforts, leadership appointments, board changes, and updates on NYSE American listing compliance matters. Investors and observers can use this news stream to follow the company’s commercial initiatives in dental and medical markets, its reimbursement and payer-access efforts, and its corporate and governance developments over time.
Milestone Scientific (NYSE American: MLSS) has received a Notice of Allowance from the European Patent Office for its innovative CompuFlo instrument, which combines minimum intensity of nerve stimulation and real-time injection pressure monitoring. This technology aims to improve ultrasound-guided peripheral nerve block (PNB) procedures by enhancing needle tip location and reducing injury risks. Developed in collaboration with experts, this advancement positions Milestone for growth in the PNB market, relevant for surgical and postoperative analgesia, with similar patent applications underway in the U.S.
Milestone Scientific (NYSE American:MLSS) has commenced the sale of its CompuFlo® / CathCheck™ disposables to the Medical University of South Carolina (MUSC), the top-ranked hospital in South Carolina. President Arjan Haverhals highlighted that this follows extensive testing by MUSC's team, reflecting a positive reception of the technologies. The CompuFlo system is noted to decrease epidural punctures and save time for anesthesiologists, while the CathCheck technology enhances catheter placement confirmation efficiency. These innovations may offer economic advantages for healthcare institutions.
Milestone Scientific Inc. (MLSS) announced a Notice of Allowance from the USPTO for its new CompuPulse System, which integrates the company's CompuWave™ technology with a manual syringe.
This development aims to enhance drug delivery safety and efficiency by verifying needle and catheter placement, thereby expanding the company's intellectual property and market reach. The CompuPulse System provides a cost-effective alternative for procedures that do not require advanced technology, while ensuring reliable confirmation during injections.
Milestone Scientific (NYSE:MLSS) announced its entry into the German market with the sale of the CompuFlo Epidural Instrument to the University Hospital of Würzburg. This agreement highlights the increasing recognition of the CompuFlo technology, which aims to enhance safety in epidural procedures by reducing accidental dural punctures. The company's leadership expressed optimism about expanding its global presence and accelerating commercialization efforts following this initial order from a prestigious European medical institution.
Milestone Scientific Inc. (MLSS) announced the expansion of its distributor network, signing agreements with Goetze Dental, Midwest Dental Equipment & Supply, and Scott's Dental in the U.S., along with Dental Fix Canada. This growth follows a rapid increase in partnerships, bringing the total to eight distributors in North America in less than a month. CEO Arjan Haverhals indicated that this strategy strengthens their position in the dental market, allowing for accelerated efforts in new global markets.
Milestone Scientific (NYSE: MLSS) announced its participation in the virtual Winter Wonderland Conference, hosted by The MicroCap Rodeo, from February 16th to 19th, 2021. The company’s Interim CEO Leonard Osser and President Jan Adriaan Haverhals will present on February 16th at 3:00 PM ET. The conference features top investment ideas and allows for one-on-one video meetings with qualified institutional investors. Milestone specializes in advanced injection technologies aimed at improving efficiency and patient comfort.
Milestone Scientific Inc. (MLSS) announced two new distribution agreements with Atlanta Dental and Nashville Dental for its Wand® Single Tooth Anesthesia (STA) System. This expands its distribution network in the U.S. to four independent distributors within a month, demonstrating growing market demand for its dental instruments. CEO Arjan Haverhals emphasized the significance of these distributors in boosting sales and supporting dental practices. The company aims to implement a three-year strategy to expand globally and enhance marketing efforts for future growth.
Milestone Scientific (NYSE American: MLSS) announced the receipt of a Notice of Allowance from the USPTO for a patent related to the disposable component of its CompuFlo® Instrument. This patent aims to enhance safety and control through an embedded micro-chip security feature, preventing unauthorized reuse of disposables. Dr. Mark Hochman emphasized the patent's importance for long-term financial success and the company's leadership in the market, holding over 20 related patents.
Milestone Scientific (NYSE American:MLSS) has announced new agreements with US Dental Depot and IQ Dental Supply to distribute its Wand® Single Tooth Anesthesia (STA) System. These agreements enhance coverage in Florida, New York, and New Jersey, indicating a rebound in demand for the product. CEO Arjan Haverhals expressed optimism about the partnerships, while Interim CEO Leonard Osser highlighted a decentralized sales strategy aimed at targeting independent distributors. These moves are expected to drive sales growth in the dental market.
Milestone Scientific (NYSE American: MLSS) has initiated sales of CompuFlo® Epidural and CathCheck disposables to Regional Medical Center (RMC) in South Carolina. This follows successful testing at RMC and aligns with Milestone's strategy to enhance revenue through disposable sales. Interim CEO Leonard Osser noted that the company’s sales pipeline is the strongest in its history, and they aim to establish CompuFlo as the standard in labor and delivery anesthesia across the U.S.